Article info

Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

Authors

  1. Correspondence to Ioannis Parodis, Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; ioannis.parodis{at}ki.se
View Full Text

Citation

Parodis I, Lindblom J, Barturen G, et al
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

Publication history

  • Received July 30, 2023
  • Accepted February 5, 2024
  • First published February 19, 2024.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.